Emergent BioSolutions (EBS) Gross Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted Gross Margin of 26.55% for Q3 2026, down 36.28 percentage points from 62.83% a year earlier and down 32.01 percentage points from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Gross Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Gross Margin at Emergent BioSolutions was 48.42%, down 6.03 percentage points year-over-year; for FY2025, it came in at 56.09%, up 21.37 percentage points from FY2024.
- Annual Gross Margin shows a five-year change of -9.86 percentage points (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Gross Margin was 34.72% in FY2024 (+1.94 pp), 32.77% in FY2023 (-5.20 pp), 37.98% in FY2022 (-19.84 pp) and 57.82% in FY2021 (-8.13 pp).
- The Q3 2026 figure stands as the lowest quarterly Gross Margin since Q2 2024.
- On a year-over-year basis, Gross Margin increased in six of the last eight quarters, with an average year-over-year change of +6.87 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q2 2025, with a gain of 68.77 percentage points; the weakest was Q2 2024, with a drop of 59.85 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 58.56% (Q2 2026), 53.88% (Q1 2026) and 42.91% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | 26.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.55% |
| Jun 30, 2026 | 58.56% |
| Mar 31, 2026 | 53.88% |
| Dec 31, 2025 | 42.91% |
| Sep 30, 2025 | 62.83% |
| Jun 30, 2025 | 52.52% |
| Mar 31, 2025 | 60.17% |
| Dec 31, 2024 | 39.39% |
| Sep 30, 2024 | 58.27% |
| Jun 30, 2024 | -16.25% |
| Mar 31, 2024 | 51.86% |
| Dec 31, 2023 | 33.08% |
| Sep 30, 2023 | 34.64% |
| Jun 30, 2023 | 43.59% |
| Mar 31, 2023 | 6.94% |
| Dec 31, 2022 | 33.22% |
| Sep 30, 2022 | 38.64% |
| Jun 30, 2022 | 30.01% |
| Mar 31, 2022 | 48.85% |
| Dec 31, 2021 | 72.23% |
API Access
Emergent BioSolutions Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();